Halpryn Glenn L
SEC-identified person · CIK 938439 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Niagen Bioscience, Inc. NAGE | Director | filed 2010 - 2015 |
| Castle Brands Inc ROX | Director | filed 2008 - 2015 |
| Sorrento Therapeutics, Inc. SRNEQ | Director · CEO and President | filed 2008 - 2012 |
| SG Blocks, INC. SGBX*** | Director | filed 2010 - 2010 |
| Tiger Media, Inc. IDI | Director | filed 2009 - 2010 |
| Winston Pharmaceuticals, Inc. WPHM | Director · Chairman, CEO, President | filed 2007 - 2009 |
| Ideation Acquisition Corp. IDI | Director | filed 2008 - 2008 |
| Tiger X Medical, Inc. clik | Director · Chairman, CEO, President | filed 2007 - 2008 |
| Ivax Diagnostics INC IVD | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.